ReviewCancer management and research2022
The Future of Lung Cancer Screening: Current Challenges and Research Priorities.
Review in Cancer management and research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Digital Interventions to Support Lung Cancer Screening: A Systematic Review.American journal of preventive medicine · 2024Pooled it
- Article
- Article
- Article
- Low-Dose radiation risk in medicine: a look at risk models, challenges, and future prospects.Zeitschrift fur medizinische Physik · 2025Review
- Article
- Optimal Pathways to Lung Cancer Screening in Primary Care Settings: A Scoping Review.Current oncology (Toronto, Ont.) · 2024Article
- Augmented fluoroscopy-guided dye localization for small pulmonary nodules in hybrid operating room: intrathoracic stamping versus transbronchial marking.International journal of computer assisted radiology and surgery · 2024Observational
- Nontraumatic intraoperative pulmonary nodule localization with laser guide stamping in a hybrid operating room.Updates in surgery · 2024Article
- Current Evidence for a Lung Cancer Screening Program.Portuguese journal of public health · 2024Review
- Investigating socioeconomic disparities in lung cancer diagnosis, treatment and mortality: an Italian cohort study.BMC public health · 2024Observational
- Assessing, updating and utilising primary care smoking records for lung cancer screening.BMC pulmonary medicine · 2023Article
- ERS International Congress 2022: highlights from the Thoracic Oncology Assembly.ERJ open research · 2023Article
- ATR-FTIR Spectroscopy with Chemometrics for Analysis of Saliva Samples Obtained in a Lung-Cancer-Screening Programme: Application of Swabs as a Paradigm for High Throughput in a Clinical Setting.Journal of personalized medicine · 2023Article
- National lung cancer screening program feasibility study in Estonia.Interdisciplinary cardiovascular and thoracic surgery · 2023Article
- What is next for occupational cancer epidemiology?Scandinavian journal of work, environment & health · 2022Article
- Possible Bias in Supervised Deep Learning Algorithms for CT Lung Nodule Detection and Classification.Cancers · 2022Review
- Potential of Inflammatory Protein Signatures for Enhanced Selection of People for Lung Cancer Screening.Cancers · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer is the leading cause of cancer-related deaths worldwide, primarily because most people present when the stage is too advanced to offer any reasonable chance of cure. Over the last two decades, evidence has accumulated to show that early detection of lung cancer, using low-radiation dose computed tomography, in people at higher risk of the condition reduces their mortality. Many countries are now making progress with implementing programmes, although some have concerns about cost-effectiveness. Lung cancer screening is complex, and many factors influence clinical and cost-effectiveness. It is important to develop strategies to optimise each element of the intervention from selection and participation through optimal scanning, management of findings and treatment. The overall aim is to maximise benefits and minimise harms. Additional integrated interventions must include at least smoking cessation. In this review, we summarize the evidence that has accumulated to guide optimisation of lung cancer screening, discuss the remaining open questions about the best approach and identify potential barriers to successful implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.